BR0116069A - Esteróide de (14beta,17alfa)-17-(hidroximetila), uso do esteróide, composição farmacêutica, e, conjunto para a contracepção masculina - Google Patents
Esteróide de (14beta,17alfa)-17-(hidroximetila), uso do esteróide, composição farmacêutica, e, conjunto para a contracepção masculinaInfo
- Publication number
- BR0116069A BR0116069A BR0116069-9A BR0116069A BR0116069A BR 0116069 A BR0116069 A BR 0116069A BR 0116069 A BR0116069 A BR 0116069A BR 0116069 A BR0116069 A BR 0116069A
- Authority
- BR
- Brazil
- Prior art keywords
- steroid
- hydroxymethyl
- 17alfa
- 14beta
- pharmaceutical composition
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title abstract 7
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000001548 androgenic effect Effects 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical class O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"ESTERóIDE DE (14BETA,17ALFA)-17-(HIDROXIMETILA), USO DO ESTERóIDE, COMPOSIçãO FARMACêUTICA, E, CONJUNTO PARA A CONTRACEPçãO MASCULINA". São divulgados esteróides androgênicos do tipo (14<225>, 17<244>)-17(hidroximetila). A invenção diz respeito a um melhoramento deste, que é fundamentado na presença de um grupo ciclopropila anelado <225>-orientado que inclui os átomos de carbono 16 e 17 do esqueleto do esteróide, isto é, uma porção de 16,17<225>-metileno. Estes esteróides apresentam uma potência androgênica inesperadamente alta.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00204459 | 2000-12-11 | ||
PCT/EP2001/014481 WO2002048171A1 (en) | 2000-12-11 | 2001-12-05 | Methylene steroids as novel androgens |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0116069A true BR0116069A (pt) | 2004-02-17 |
Family
ID=8172416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0116069-9A BR0116069A (pt) | 2000-12-11 | 2001-12-05 | Esteróide de (14beta,17alfa)-17-(hidroximetila), uso do esteróide, composição farmacêutica, e, conjunto para a contracepção masculina |
Country Status (18)
Country | Link |
---|---|
US (1) | US6949531B2 (pt) |
EP (1) | EP1343806B1 (pt) |
JP (1) | JP4279552B2 (pt) |
CN (1) | CN1226304C (pt) |
AR (1) | AR035404A1 (pt) |
AT (1) | ATE397010T1 (pt) |
AU (2) | AU2002224923B2 (pt) |
BR (1) | BR0116069A (pt) |
CA (1) | CA2431355C (pt) |
CY (1) | CY1108172T1 (pt) |
DE (1) | DE60134266D1 (pt) |
DK (1) | DK1343806T3 (pt) |
ES (1) | ES2305131T3 (pt) |
IL (2) | IL156175A0 (pt) |
MX (1) | MXPA03005224A (pt) |
PE (1) | PE20020688A1 (pt) |
PT (1) | PT1343806E (pt) |
WO (1) | WO2002048171A1 (pt) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3732209A (en) * | 1971-03-15 | 1973-05-08 | Hoffmann La Roche | Novel 17beta-oxygenated cyclopropa(16alpha,17alpha)steroids |
US6881728B1 (en) * | 1999-03-08 | 2005-04-19 | Akzo Nobel N.V. | 14-β, 17-α-hydroxymethylandrostane derivatives as androgens |
-
2001
- 2001-12-05 CA CA002431355A patent/CA2431355C/en not_active Expired - Lifetime
- 2001-12-05 AU AU2002224923A patent/AU2002224923B2/en not_active Expired
- 2001-12-05 MX MXPA03005224A patent/MXPA03005224A/es active IP Right Grant
- 2001-12-05 DK DK01994774T patent/DK1343806T3/da active
- 2001-12-05 WO PCT/EP2001/014481 patent/WO2002048171A1/en active IP Right Grant
- 2001-12-05 US US10/450,278 patent/US6949531B2/en not_active Expired - Lifetime
- 2001-12-05 ES ES01994774T patent/ES2305131T3/es not_active Expired - Lifetime
- 2001-12-05 IL IL15617501A patent/IL156175A0/xx unknown
- 2001-12-05 DE DE60134266T patent/DE60134266D1/de not_active Expired - Lifetime
- 2001-12-05 EP EP01994774A patent/EP1343806B1/en not_active Expired - Lifetime
- 2001-12-05 BR BR0116069-9A patent/BR0116069A/pt not_active IP Right Cessation
- 2001-12-05 AT AT01994774T patent/ATE397010T1/de active
- 2001-12-05 CN CNB018203329A patent/CN1226304C/zh not_active Expired - Lifetime
- 2001-12-05 JP JP2002549702A patent/JP4279552B2/ja not_active Expired - Lifetime
- 2001-12-05 PT PT01994774T patent/PT1343806E/pt unknown
- 2001-12-05 AU AU2492302A patent/AU2492302A/xx active Pending
- 2001-12-10 PE PE2001001232A patent/PE20020688A1/es not_active Application Discontinuation
- 2001-12-10 AR ARP010105713A patent/AR035404A1/es active IP Right Grant
-
2003
- 2003-05-28 IL IL156175A patent/IL156175A/en not_active IP Right Cessation
-
2008
- 2008-07-02 CY CY20081100695T patent/CY1108172T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002048171A1 (en) | 2002-06-20 |
AU2492302A (en) | 2002-06-24 |
JP2004517091A (ja) | 2004-06-10 |
PE20020688A1 (es) | 2002-08-03 |
ATE397010T1 (de) | 2008-06-15 |
PT1343806E (pt) | 2008-07-04 |
ES2305131T3 (es) | 2008-11-01 |
US20040030165A1 (en) | 2004-02-12 |
CA2431355A1 (en) | 2002-06-20 |
CN1479747A (zh) | 2004-03-03 |
CN1226304C (zh) | 2005-11-09 |
MXPA03005224A (es) | 2004-03-26 |
JP4279552B2 (ja) | 2009-06-17 |
DE60134266D1 (de) | 2008-07-10 |
DK1343806T3 (da) | 2008-09-22 |
US6949531B2 (en) | 2005-09-27 |
AU2002224923B2 (en) | 2007-01-04 |
IL156175A (en) | 2009-08-03 |
CY1108172T1 (el) | 2014-02-12 |
EP1343806B1 (en) | 2008-05-28 |
AR035404A1 (es) | 2004-05-26 |
CA2431355C (en) | 2009-11-24 |
EP1343806A1 (en) | 2003-09-17 |
IL156175A0 (en) | 2003-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP055629A (es) | COMPOSICIÓN QUE CONTIENE UN ESTEROIDE 11ß-HALOGENADO ANDRÓGENO Y UN GESTÁGENO ASÍ COMO UN CONTRACEPTIVO MASCULINO SOBRE LA BASE DE ESTAS COMPOSICIONES | |
BR0107445A (pt) | Formulação farmacêutica, uso de fulvestrante na preparação de uma formulação farmacêutica, e, seringa ou frasco | |
RS50972B (sr) | Farmaceutski sastav koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate | |
BRPI0512993A (pt) | uso de um antagonista de pr, kit farmaceuticamente últil, e, método de contracepção em uma fêmea em idade de parto | |
BR9908094A (pt) | Preparado combinado de estrogênio e antiestrogênio | |
RU2009102772A (ru) | 18-метил-19-норандрост-4-ен-17, 17-спироэфир (18-метил-19-нор-20-спирокс-4-ен-3-он) и фармацевтические препараты, которые его содержат | |
BR9809703A (pt) | Acilanilidas (hetero) ciclicamente substituìdas, não esteroidais, com eficácia gestagênica e androgênica mista | |
ES2320626T5 (es) | Procedimiento para la preparación de drospirenona | |
DK0680327T3 (da) | Terapeutiske anvendelser af og leveringssystemer for dehydroepiandrosteron | |
BR0012489A (pt) | Composto, composição farmacêutica, uso de um composto, e, kit para a contracepção masculina | |
KR970706001A (ko) | 습식-과립화를 통해 투여단위를 제조하는 방법 (process of making dosage units by wet granulation) | |
DK0771217T3 (da) | Faste lægemiddelformer, som indeholder clathrater af det steroide könshormon ethinylestadiol | |
BR9913457A (pt) | Neuroproteção | |
BR0116069A (pt) | Esteróide de (14beta,17alfa)-17-(hidroximetila), uso do esteróide, composição farmacêutica, e, conjunto para a contracepção masculina | |
BR0013769A (pt) | Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide | |
PA8633801A1 (es) | Derivados de sulfamoilbenzoato y sulfamoilaminobenzoato de estriol, y derivados de sulfamoilbenzoato y sulfamoilaminobenzoato de estetrol | |
BR0011680A (pt) | Agonistas receptores de somatostatina neuromedina b, seu uso e composição farmacêutica compreendendo os mesmos | |
BR0214607A (pt) | Processo para a obtenção de estrogênios de urina de éguas | |
CA1202301A (en) | 7.alpha.-ACYLTHIO-15,16-METHYLENE-3-OXO-17.alpha.-PREGNA-1,4- DIENE-21,17-CARBOLACTONES, PROCESS FOR THE PREPARATION THEREOF, AND USE THEREOF AS MEDICINAL AGENTS | |
MX9303970A (es) | COMPUESTOS ESTEROIDALES DE ANILLO A DE 17Ó Y 17ß-ALQUILCETONA-3-CARBOXIAROMATICO. | |
BR0112791A (pt) | Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica | |
PE20010581A1 (es) | Mesoprogestinas (modulares de receptores de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (hrt) | |
PE20000330A1 (es) | Nuevo kit anticonceptivo | |
DK0559706T3 (da) | 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer. | |
BR9803129A (pt) | Composto de (17alfa) - 17 hidróxi-11 metileno-19 norpregna-4,15-dieno-20-in-3-ona cristalino, composição farmacêutica sólida e processo para a preparação e uso do composto de (17alfa)-17-hidróxi-11-metileno-19 norpregna-4, 15-dieno-20-in-3-ona cristalino. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2258 DE 15/04/2014. |